Arcoma AB

OM:ARCOMA 株式レポート

時価総額：SEK 138.4m

Arcoma マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Mattias Leire

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間1.8yrs
CEOの所有権n/a
経営陣の平均在職期間1.8yrs
取締役会の平均在任期間7.8yrs

経営陣の近況

Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Jan 14
Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Recent updates

Lacklustre Performance Is Driving Arcoma AB's (STO:ARCOMA) 28% Price Drop

Nov 09
Lacklustre Performance Is Driving Arcoma AB's (STO:ARCOMA) 28% Price Drop

Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

Aug 22
Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

At kr15.20, Is Arcoma AB (STO:ARCOMA) Worth Looking At Closely?

Aug 07
At kr15.20, Is Arcoma AB (STO:ARCOMA) Worth Looking At Closely?

Is Now The Time To Look At Buying Arcoma AB (STO:ARCOMA)?

Apr 26
Is Now The Time To Look At Buying Arcoma AB (STO:ARCOMA)?

Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 06
Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Arcoma (STO:ARCOMA) A Risky Investment?

Jan 15
Is Arcoma (STO:ARCOMA) A Risky Investment?

We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt

Sep 11
We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt

Is Arcoma (STO:ARCOMA) Using Too Much Debt?

Jun 08
Is Arcoma (STO:ARCOMA) Using Too Much Debt?

Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Apr 27
Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?

Dec 22
Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?

Is Arcoma (STO:ARCOMA) Using Too Much Debt?

May 03
Is Arcoma (STO:ARCOMA) Using Too Much Debt?

These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively

Oct 28
These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively

Is Arcoma (STO:ARCOMA) A Risky Investment?

Mar 17
Is Arcoma (STO:ARCOMA) A Risky Investment?

Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Feb 04
Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Jan 14
Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Jan 12
Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well

Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)

Nov 21
Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)

CEO（最高経営責任者

Mattias Leire (43 yo)

1.8yrs

在職期間

Mr. Mattias Leire is Chief Executive Officer of Arcoma AB from February 2023. He joined the Arcoma AB in 2023. He has extensive experience from leading positions, including many years within Atos Medical....

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Mattias Leire
Chief Executive Officer1.8yrsデータなしデータなし
Johan Dahlberg
Chief Financial Officer2.5yrsデータなしデータなし
Daniel Warawasowski
Global Sales Directorless than a yearデータなしデータなし

1.8yrs

平均在職期間

41yo

平均年齢

経験豊富な経営陣: ARCOMAの経営陣は 経験豊富 とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称ポジション在職期間報酬所有権
Jan Wahlstrom
Independent Director2.5yrsSEK 100.00kデータなし
Mats Thoren
Director14.8yrsSEK 100.00kデータなし
Lars Kvarnhem
Chairman7.8yrsSEK 400.00kデータなし

7.8yrs

平均在職期間

53yo

平均年齢

経験豊富なボード: ARCOMAの 取締役会 は 経験豊富 であると考えられます ( 7.8年の平均在任期間)。